tirzepatide for obesity fda approval Approves Tirzepatide, A Potential Blockbuster Drug Type 2 Diabetes Zepbound® — A New Treatment

Explaining why GLP-1 drugs improve health without weight loss defies simple narratives and confounds researchers

PMCID: PMC3845706

These medications are not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), certain gastrointestinal conditions, or those who are pregnant or breastfeeding

They can be a cause for excessive bleeding for those taking anticoagulant medication and may exacerbate symptoms if taken together continuously in large doses

Gently press and pat onto your face and neck

GLP-1 shots like liraglutide and semaglutide ran their own heart trials and cut cardiovascular events too